• - Data for masked anti-CTLA-4 SAFEbody ADG126 (muzastotug)

    Source: Buzz FX / 29 Mar 2024 09:06:20   America/New_York


    - Data for masked anti-CTLA-4 SAFEbody ADG126 (muzastotug) highlight best-in-class therapeutic index and demonstrate clinical benefits in metastatic microsatellite-stable (MSS) colorectal cancer (CRC) with higher, more frequent and repeat
    Read more...
Share on,